MedTrace Logo

Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block

NCT02718976 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-04-26

No results posted yet for this study

Summary

The main objective is to complete a double-blinded randomized controlled crossover trial of lumbar plexus block with the Shamrock technique guided by ultrasound (US)/magnetic resonance imaging (MRI) image fusion vs. the Shamrock technique guided by ultrasound in healthy volunteers.

The investigators will assess block procedure-related parameters, anatomical spread of local anesthetic, and motor and sensory effects.

Conditions

  • Hip Fractures
  • Anesthesia, Local
  • Pain, Postoperative

Interventions

PROCEDURE

Ultrasound/MR image fusion guided lumbar plexus block (Shamrock)

PROCEDURE

Ultrasound guided lumbar plexus block (Shamrock)

DRUG

Lidocaine-epinephrine added gadoterate meglumine

Perineural injection of 20 ml 2% lidocaine with 0.0005% epinephrine added 1 ml of gadoterate meglumine (0.13 ml) and sodium chloride (NaCl, 0.87 ml). The 1 ml of gadoterate meglumine-NaCl is added to the local anesthetic prior to the perineural injection in order to enhance visualization of the local anesthetic on MRI scanning after the intervention.

Sponsors & Collaborators

  • Bendtsen, Thomas Fichtner, M.D, Ph.D.

    collaborator UNKNOWN

  • AP Moeller Foundation

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Jennie MC Strid, M.D. · Department of Anesthesiology and Intensive Care, Aarhus University Offical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-04-30
Completion
2016-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02718976 on ClinicalTrials.gov